A closer look · Biomarkers and uncertainty
What can a tumour test tell us?
Explore four invented test summaries. Distinguish a potentially useful result from a test limitation or an uncertain finding.
Invented summaries, not laboratory reports. No real gene, patient, drug or eligibility rule is modelled. The examples explain kinds of information, rather than interpreting your results.
Fictional summary · Not a laboratory report
- Technical result
- Finding
- What this supports
Ask the team
Example / Potentially useful marker
Useful information. Still part of a wider decision.
In this invented example, an appropriate test finds a feature that has established relevance to a treatment for this cancer. That may help the team discuss an option. It does not show that the treatment will work for this person, or that its benefits outweigh its risks.
A treatment discussion, without a guarantee of benefit.
Example / No relevant marker found
Not found by this test does not mean no options.
In this invented example, the test produces a reliable answer but does not find a treatment-relevant marker within the features it examines. Other cancer treatments may still be useful. The result is not the same as saying that no cancer is present or that all possible tests were negative.
A result for the question tested, not a verdict on every treatment.
Example / Not enough tissue
No reliable result is different from a negative result.
In this invented example, too little suitable tumour material is available. The laboratory cannot answer the intended question reliably. Whether another sample or a different test is appropriate depends on safety, the cancer and whether the answer could affect the plan.
A limitation of testing, rather than proof that a marker is absent.
Example / Uncertain finding
Finding a change does not establish what to do with it.
In this invented example, a genetic change is reported but its significance is uncertain. The finding alone is not an established reason to choose a matching cancer treatment. The oncology and laboratory teams interpret the result alongside the evidence and the other clinical findings.
An uncertain finding, rather than an established treatment target.
Which question is the test answering?
Treatment information
Biomarker tests can examine genes, proteins or other features relevant to a cancer. Different tests answer different questions; not every cancer needs every available test.
Test findings sit alongside the diagnosis, extent of disease, previous treatment and health of the person. A result is not a complete plan.
Inherited risk is a separate question
A change found in a tumour is not automatically inherited. Some results raise a question that needs further assessment or a separate test for an inherited predisposition.
Ask what was tested and whether the result has any implications for relatives. This lesson cannot establish inherited risk.
These examples are deliberately limited. They do not cover every possible result, assay, change in a tumour over time, access pathway or reason for testing.
Pause and consider
If a tumour test finds a genetic change, does that prove it was inherited?
No. Tumour testing and testing for an inherited predisposition answer different questions. A tumour result can sometimes raise an inherited-risk question, but appropriate further assessment is needed to establish what it means for the person or their family.
Useful next reading
Sources & clinical review
Clinically reviewed and approved by Dr AlHilali on 4 November 2026.